Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Aberrant transcript usage induces homologous recombination deficiency and predicts therapeutic responses

PROVIDER: PRJNA700673 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13660800.fastq.gz	Fastqsanger.gz
	SRR13660800_1.fastq.gz	Fastqsanger.gz
	SRR13660800_2.fastq.gz	Fastqsanger.gz
	SRR13660900_1.fastq.gz	Fastqsanger.gz
	SRR13660900_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 677

Similar Datasets

ILF3 safeguards telomere from aberrant homologous recombination as a telomeric R-loop reader

Project description:Here we found that ILF3 prefers to bind telomere R-loops and protects telomere from aberrant homologous recombination. ILF3 knockout induces TERRA aggregation onto telomere and activates telomere DNA damage response (DDR). Furthermore, ILF3 deficiency disrupts telomere homeostasis and induces abnormal ALT-mediated telomere lengthening

2022-03-04 | PXD032093 |

A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors

Project description:HS-10502 is a Poly(ADP-ribose) polymerase 1 (PARP1)-specific selective inhibitor. The purpose if this study is to assess the safety, tolerability, pharmacokinetics (PK), and efficacy of HS-10502 in subjects with homologous recombination repair (HRR) gene mutant or homologous recombination deficiency (HRD) positive advanced solid tumors.

| 9330 | ecrin-mdr-crc

The Efficacy and Safety of Fluzoparib Plus Irinotecan as Second-line Treatment in Patients With Homologous Recombination Deficiency (HRD) Metastatic Colorectal Cancer.

Project description:Preclinical data support the investigation of PARP inhibitors in other neoplasms exhibiting homologous recombination deficiency (HRD) as monotherapy as well as in combination with chemotherapy. However，in colorectal cancer (CRC), the role of HRD alterations is mostly unknown. This study aims to explore the the Efficacy and Safety of Fluzoparib combined with Irinotecan in the Second-line treatment of HRD alterations metastatic colorectal cancer.

| 8652 | ecrin-mdr-crc

1f21bafd-41c5-4cf4-a15f-79dc22e91491 - samples

Project description:Homologous recombination deficiency (HRD) score in a large cohort of 55 triple-negative breast cancer PDX

| EGAD00001008839 | EGA

Senataxin promotes recombination fidelity during antigen receptor gene diversification

Project description:Immunoglobulin (Ig) and T cell receptor (TCR) V(D)J gene recombination relies on non-homologous end-joining (NHEJ), which repairs DNA double-strand breaks (DSBs) introduced by the RAG1/2 nuclease complex. Functional redundancies exist between NHEJ and the ATM kinase-dependent chromatin DSB response, likely masking the activity of additional factors. Here, we performed parallel targeted CRISPR-Cas9 screens in pro-B cells and found that Senataxin (SETX) participates in V(D)J recombination. We find that SETX supports V(D)J recombination, particularly in condition of ATM kinase inhibition or XLF deficiency. Furthermore, we show that SETX suppresses the formation of aberrant coding end-to-signal end hybrid joints during V(D)J recombination and prevents the aberrant joining of AID-induced DNA ends during Ig heavy chain class switching, revealing an essential role for SETX in promoting recombination fidelity during antigen receptor gene diversification.

2025-06-23 | GSE300403 | GEO

Project description:Homologous recombination deficiency status of Korean ovarian cancer patients

| PRJNA1065932 | ENA

DAXX Suppression of ALT

Project description:<p>Many tumors maintain chromosome ends through a telomerase-independent, homologous recombination based mechanism called alternative lengthening of telomeres (ALT). While ALT occurs in only a subset of tumors, it is strongly associated with mutations in the genes encoding components of the histone H3.3 chaperone complex, ATRX and DAXX. To date the mechanistic role of ATRX and particularly DAXX mutations in potentiating ALT remains poorly understood. We identify an osteosarcoma cell line, G292, with a unique chromosomal translocation resulting in loss of DAXX function, while retaining functional ATRX. Using this distinctive resource, we demonstrate that introduction of wild type DAXX suppresses the ALT phenotype and restores localization of the ATRX/DAXX complex to PML bodies. This provides the first direct molecular evidence that ongoing DAXX deficiency is essential for maintenance of the ALT phenotype and highlights the potential for therapeutic targeting of this oncogenic pathway.</p>

| phs001495 | dbGaP

The Greatwall kinase safeguards the genome integrity by balancing the kinome activity in mitosis.

Project description:Mastl is commonly overexpressed in cancer, appearing as an alternative therapeutic anticancer target. Loss of Mastl induces multiple chromosomal mitotic errors that lead to the accumulation of micronuclei and multilobulated cells with polyploidy. Our detailed analyses display that loss of Mastl quickly lead to chromosomes breakage and abnormalities impairing correct segregation. Phosphoproteomic data of mouse embryonic fibroblasts revealed defects in kinetochores, perichromosomes, and centrosomes but also on RNA binding proteins and double strand DNA damage repair.In our study, Rad51ap1, a well-known homologous recombination regulator, appeared to be effectively phosphorylated by Nek2 and CDK1, but also efficiently depshosphorylated by PP2A/B55. Taken together, these results suggest that Mastl loss induces a multitude of alteration even in noncancerous cells that lead to the disruption of DNA damage repair triggering chromosomes breakage and in consequence, creates an accumulative disequilibrium in the phosphoproteome.

2020-10-15 | PXD019297 | JPOST Repository

Genetic studies of homologous recombination deficiency in hispanic gastric cancer

Project description:Genetic studies of homologous recombination deficiency in hispanic gastric cancer

| PRJNA951869 | ENA

Genetic studies of homologous recombination deficiency in hispanic gastric cancer

Project description:Genetic studies of homologous recombination deficiency in hispanic gastric cancer

| PRJNA951870 | ENA